Clinical Trials

2,250 enrolled

Glioblastoma, Recurrence

NCT03315364 2026-04-01

OPTIMAL

549 enrolled

Breast

Breast Neoplasms, Recurrence

NCT07502118 2026-03-30

NexCAR19

40 enrolled

Cytokine Release Syndrome, Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02491632 2026-03-18

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

90 enrolled 13 charts

Fatigue, Neoplasm Metastasis, Neoplasms, Recurrence

NCT03021486 2026-03-18

Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer

70 enrolled 20 charts

Delirium, Neoplasm Metastasis, Recurrence

NCT07366801 2026-01-26

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

64 enrolled

Recurrence, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02598661 2026-01-05

Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

289 enrolled 35 charts 2 FDA

Myeloid

Myelodysplastic Syndromes, Recurrence

NCT03743649 2025-12-26

Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

110 enrolled

Delirium, Neoplasm Metastasis, Recurrence

NCT04442022 2025-10-03

A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

501 enrolled

Phase 2/3 Not yet recruiting

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT07198451 2025-09-30

GEM-IR-NMIBC

320 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT06908772 2025-04-03

Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer Patients

Phase 2/3 Not yet recruiting

390 enrolled

Recurrence

NCT05595447 2025-03-12

Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma

20 enrolled

Phase 2/3 Not yet recruiting

Hodgkin Disease, Recurrence

NCT06719479 2024-12-05

A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

60 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT04155424 2024-09-25

A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder

5 enrolled 15 charts

Demyelinating Diseases, Myelitis, Transverse, Neuromyelitis Optica, Optic Neuritis, Recurrence

NCT06241599 2024-02-05

A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

300 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Recurrence

NCT02634294 2023-03-16

Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT

Other hematologic neoplasm

30 enrolled

Graft vs Host Disease, Recurrence, Hematologic Neoplasms

NCT01518517 2022-02-02

GRASPIVOTALL

85 enrolled 13 charts

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02910063 2021-01-13

Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL

41 enrolled 18 charts

Leukemia, Neoplasms, Recurrence, Lymphoma, B-Cell

NCT01774578 2020-05-28

Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer

135 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT02673008 2020-02-25

MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT

206 enrolled

Recurrence, Neoplasm, Residual

NCT02414165 2020-02-07

Toca5

403 enrolled

Astrocytoma, Glioblastoma, Recurrence

NCT01197560 2019-11-25

Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

111 enrolled 20 charts

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02186301 2019-05-07

EGFR

100 enrolled 14 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT00749723 2018-07-20

HIT-REZ-2005

174 enrolled

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence

NCT01458717 2018-05-02

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

58 enrolled

Gastrointestinal

Neoplasms, Pancreatic Neoplasms, Recurrence

NCT03427034 2018-02-09

ABSEIL

2,100 enrolled

Genitourinary

Urinary Bladder Neoplasms, Hematuria, Recurrence

NCT03391726 2018-01-05

CCFRRBL

20 enrolled

Recurrence, Lymphoma, B-Cell

NCT01211938 2017-05-16

JANORL2

60 enrolled

Carcinoma, Squamous Cell, Recurrence

NCT01961934 2016-09-28

C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression

Phase 2/3 Withdrawn

Glioblastoma, Glioma, Recurrence

NCT01639638 2015-03-12

Recurrent and Nonrecurrent Condyloma Treatment

132 enrolled

Condylomata Acuminata, Recurrence

NCT00070187 2013-10-17

Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

24 enrolled

Hodgkin Disease, Lymphoma, Recurrence

NCT01423032 2011-08-25

Bendamustine Versus Fludarabine in Chronic Lymphocytic Leukemia (CLL)

96 enrolled

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00561522 2010-07-21

Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection

290 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasm Metastasis, Recurrence

NCT00816075 2009-02-17

Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection

40 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT00165633 2008-12-09

A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma